# Multiplex High Resolution Melting Using MADC2 and SCAR Markers for Sex Identification > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/multiplex-high-resolution-melting-plant-sex-identification/ > **Published:** 2026-04-01T18:05:23-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:22:44-04:00 > **Clinical Summary:** Explore multiplex high resolution melting techniques using MADC2 and SCAR markers for accurate plant sex identification in research. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Research MethodsPlant BiologyNon-Clinical Why This Matters This appears to be a research methodology paper on plant sex identification techniques, which has no direct clinical relevance for [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) or patient care. The title suggests laboratory methods for determining plant sex rather than therapeutic applications. Clinical Summary Based on the incomplete title referencing multiplex high resolution melting and molecular markers (MADC2 and SCAR), this appears to be a botanical or agricultural genetics study focused on sex determination in plants. Clinical Perspective 🧠 This type of plant genetics research may have agricultural applications but does not inform clinical decision-making regarding cannabis therapeutics. Clinicians should focus on peer-reviewed studies that directly examine patient outcomes, dosing, safety profiles, or therapeutic mechanisms. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Multiplex%20high%20resolution%20melting%20using%20MADC2%20and%20SCAR%20markers%20for%20sex%20identific...%20%40drcaplan&url=https%3A//www.nature.com/articles/s41598-026-46461-6)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.nature.com/articles/s41598-026-46461-6)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Multiplex%20high%20resolution%20melting%20using%20MADC2%20and%20SCAR%20markers%20for%20sex%20identific...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.nature.com/articles/s41598-026-46461-6)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.nature.com/articles/s41598-026-46461-6](https://www.nature.com/articles/s41598-026-46461-6) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis research?](#What_is_the_clinical_relevance_rating_of_this_cannabis_research) - [What type of cannabis research is being discussed?](#What_type_of_cannabis_research_is_being_discussed) - [Why is this research considered noteworthy?](#Why_is_this_research_considered_noteworthy) - [What research areas does this study cover?](#What_research_areas_does_this_study_cover) - [How does this research fit into the broader cannabis science landscape?](#How_does_this_research_fit_into_the_broader_cannabis_science_landscape) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis research? This research has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This means the findings represent emerging developments or policy changes that warrant close monitoring by healthcare professionals. #### What type of cannabis research is being discussed? This appears to be non-clinical [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) focusing on plant biology and research methods. The study does not involve human subjects but rather examines fundamental aspects of cannabis as a plant. #### Why is this research considered noteworthy? The research has been flagged as having notable clinical interest due to emerging findings that could impact future clinical practice. While the current study is non-clinical, the results may have implications for [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) applications. #### What research areas does this study cover? The study encompasses three main areas: research methodology development, plant biology investigations, and non-clinical analysis. This multidisciplinary approach suggests comprehensive examination of cannabis-related scientific questions. #### How does this research fit into the broader cannabis science landscape? This work contributes to the foundational understanding of cannabis through plant biology research and methodological development. Such non-clinical studies often provide the scientific groundwork that enables future [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) and therapeutic applications. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Multiplex high resolution melting using MADC2 and SCAR markers for sex identification of …”, “url”: “https://www.nature.com/articles/s41598-026-46461-6”, “datePublished”: “2026-04-01T18:31:15Z”, “about”: “multiplex high resolution melting using madc2”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence Feds to close Grand Rapids lab that does global-leading research on forestry, climate change Learn about the closure of a major research lab impacting forestry and climate science, highlighting challenges in environmental research. Read More [Lighting science and advanced cultivation to take center stage at Dutch cannabis research tour](https://cedclinic.com/lighting-science-advanced-cultivation-dutch-cannabis-research/) Discover innovations in lighting science and cultivation techniques shaping the future of [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) and agriculture. [Explore Insights](https://cedclinic.com/lighting-science-advanced-cultivation-dutch-cannabis-research/) This state agency was created to investigate Texas universities. How that works is a mystery. An investigative look at a state agency's role and impact on Texas universities, raising questions about oversight and transparency. Learn More ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).